Article
12 Dec 2025
Infringement By Common Design Found In Canadian Case
AUTHORS CONTENT
Article
10 Nov 2025
Narrow Issues Of Claim Construction, Double Patenting, And Costs Determined On Appeal
Article
28 Jul 2025
Patented Medicine Prices Review Board Publishes New Guidelines For PMPRB Staff: Finally, Some Guidance For Patentees
Article
10 Jul 2025
Can One Infringe An Apparatus Patent With Mere Plans Or Drawings? The SCC's Denial Of Leave Confirms That The Answer Is No
Article
31 Jan 2025
Patent Is NOT Listed On Patent Register When Form IV Is Filed; Only When Minister Determines It Is Eligible
Article
10 Dec 2024
The FCA Concludes PMPRB Decision Re Differin® Exceeded The Board's Jurisdiction
Article
24 Nov 2023
The Patented Medicines Prices Review Board Is Consulting On New Guidelines
Article
01 Nov 2023
Active Consultation: Amendments To The Copyright Act Relating To Generative Artificial Intelligence
Article
07 Aug 2023
Much Anticipated FCA Decision In Benjamin Moore Removes Prescriptive Test Ordered By FC
Article
07 Jun 2023
Accounting Of Profits Remedy For Patent Infringement In Canada
Article
07 Jun 2023
Stopping Counterfeit Goods At The Canadian Border
Article
24 Nov 2022
SCC Provides Clarity On Accounting Of Profits Remedy In Patent Infringement
Article
08 Sep 2022
NOC Regulations Do Not Apply To Biosimilars When Reference Products Are Not Marketed
Article
13 Apr 2022
Intellectual Property Highlights In The Federal Budget 2022
Article
06 Dec 2021
Regulatory Context For Patented Pharmaceuticals And Biotechnology Drugs In Canada
Article
06 Dec 2021
Scope Of Patent Agent Privilege Provided By New Section 16.1 Considered By Court
Article
25 Jun 2021
Patent Validity Challenges In Canada
Article
17 Jun 2021
FCA Allows Defendant To Amend Pleadings To Allege Grounds Of Invalidity Not In NOA
Article
17 Mar 2021
FCA Provides Much Needed Clarification On Obviousness And Anticipation
Article
16 Mar 2021
Ontario Superior Court Dismisses Apotex's Claims For Damages Under Statutes Of Monopolies